These studies showed that domain CR9 is critical for LRP1-mediated agLDL binding and internalization in hcVSMCs and opens a new avenue for an innovative strategy in the treatment of local vascular lipid deposition in atherosclerosis. This evidence concerns the gene LRP1 and atherosclerosis.